GlassScriptPhysician profile
Lynn R Kohan
NPI 1023285129
$29,674.02
in general payments reported to CMS, 2019-2025
16 companies · $1,410 in 2025
The $1,410 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $1,988 · 2021: $5,577 · 2022: $4,787 · 2023: $1,333 · 2024: $961 · 2025: $1,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,354 · Honoraria: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,353.84 |
| Honoraria | $1,350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $23,688.21 | 2019-2025 | Cooled Rfa, Coolief* Cooled Radiofrequency |
| Relievant Medsystems, INC. | $1,372.18 | 2021-2022 | |
| Boston Scientific Corporation | $1,284.65 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $1,252.23 | 2021-2024 | Intellis Adaptivestim, Synchromedii |
| Spr Therapeutics, INC | $567.47 | 2021-2023 | Sprint Pns System |
| Medtronic USA, INC. | $346.94 | 2019 | |
| Nevro Corp. | $306.03 | 2021 | |
| Abbott Laboratories | $264.05 | 2024-2025 | Proclaim |
| Mml US, INC. | $206.18 | 2022 | |
| Grt US Holding, INC. | $144.11 | 2021-2022 | |
| Averitas Pharma INC. | $86.93 | 2023 | Qutenza |
| Stryker Corporation | $74.83 | 2019 | |
| Novartis Pharmaceuticals Corporation | $49.00 | 2019 | |
| Vertos Medical, INC. | $15.66 | 2020 | |
| Amgen INC. | $15.55 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Kohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.